Migraine Medication Telcagepant is Officially Dead
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Migraine.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
Merck kills PhIII Drug Program | Calcium Gene-Related Peptide Receptor Antagonists in the Treatment of Migraine | Olcegepant: Novel Therapy for Acute Migraine | Migraine Drug Telcagepant to Undergo Another Clinical Safety Study | Telcagepant & The Future of Migraine Prevention